Physician

Christopher Bligh Komanski, M.D.

According to 2025 Medicare claims, Christopher Komanski, M.D. (NPI: 1558781856) practices ophthalmology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE EYE ASSOCIATES PLLC (NPI: 1295799823; TIN: 561967404) and primary practice location at 28803-2493. Komanski is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Komanski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,401 traditional Medicare patients, billed 67,129 HCPCS/CPT codes, and received $2,969,706 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 550 prescription claims across 152 beneficiaries totaling $20,352 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 32 records totaling $16,642. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,286 to $2,969,706. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,554 and ending at $20,352. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2018 Medicare payment: $9,286 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $29,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $663,226 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,364,751 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,820,786 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,338,745 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,969,706 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018116166$9,286
2019266476$29,210
20204742,405$663,226
20216175,771$1,364,751
202289011,654$1,820,786
20231,07338,466$2,338,745
20241,40167,129$2,969,706

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$29K2015 Drug cost: $15,554 (USD; Tot_Drug_Cst)2016 Drug cost: $1,666 (USD; Tot_Drug_Cst)2018 Drug cost: $5,956 (USD; Tot_Drug_Cst)2019 Drug cost: $9,966 (USD; Tot_Drug_Cst)2020 Drug cost: $3,992 (USD; Tot_Drug_Cst)2021 Drug cost: $14,514 (USD; Tot_Drug_Cst)2022 Drug cost: $29,176 (USD; Tot_Drug_Cst)2023 Drug cost: $22,873 (USD; Tot_Drug_Cst)2024 Drug cost: $20,352 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201552397$15,554
2016N/R19$1,666
2017N/RN/RN/R
20183162$5,956
201978170$9,966
202043102$3,992
202180251$14,514
2022110356$29,176
2023135365$22,873
2024152550$20,352

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4632,005$90
92014Established patient complete exam of visual system1,2122,006$85
J9035Injection, bevacizumab, 10 mg205713$53
92134Imaging of retina1,1962,335$28
J2777Injection, faricimab-svoa, 0.1 mg23857,841$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1837,470$9,163
Brimonidine TartrateBrimonidine Tartrate431,951$3,209
Ketorolac TromethamineKetorolac Tromethamine872,956$1,994
DifluprednateDifluprednate16428$1,686
Atropine SulfateAtropine Sulfate331,817$1,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$16,642Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Bligh Komanski, M.D.?

Tedicare shows public-source Medicare data for Christopher Bligh Komanski, M.D. (NPI 1558781856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Bligh Komanski, M.D. have ACO affiliation data?

Christopher Bligh Komanski, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Christopher Bligh Komanski, M.D.?

Christopher Bligh Komanski, M.D. is linked to ASHEVILLE EYE ASSOCIATES PLLC (billing NPI 1295799823) in the available physician profile data.

Does Christopher Bligh Komanski, M.D. have Open Payments data?

Christopher Bligh Komanski, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.